The inflammation marker TNFAIP3, also discovered to ameliorate NAFLD and be protective against its progression [78, 79], was up-regulated among the five top DEG genes in subgroup I (Fig. 3C). The gene discussed is TNFAIP3; the disease is metabolic dysfunction-associated steatotic liver disease.